Products

Primary tabs

Export products to Excel

Displaying 91 - 105 of 111
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Pre-clinical

ROC

Alternative Name: Ulipristal acetate (UPA) Oral
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Oral
Project Stage: Phase II
Partner: HRA Pharma, NICHD
Alternative Name: Depo-subQ + Uniject
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Marketed
Partner: Pfizer, PATH, USAID
Alternative Name: SCHIELD Biodegradable MPT Implant
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Pre-clinical
Alternative Name: Zarin, Femplant, Trust
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Marketed
Alternative Name: Hormonal Intrauterine Ball
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Lead Optimization
Alternative Name: NSP-989; NSP-989 COMBO; Tanaproget COMBO; WAY-166989
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Oral
Project Stage: Phase II
Alternative Name: Tenofovir Disoproxil Fumarate (TDF) +Levonorgestrel Vaginal Ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase I
Alternative Name: TU, Aveed
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase III
Alternative Name: TV-46046
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase I
Alternative Name: Tenofovir (TFV) and levonorgestrel (LNG) ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase I
Partner: CONRAD
Alternative Name: Triclovera, OSKB -1
Development Status: Limited Market Approval
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Marketed
Alternative Name: Testosterone undecanoate (TU) + etonogestrel (ENG)
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Injectable, Subdermal
Project Stage: Phase II
Partner: Organon
Alternative Name: Testosterone undecanoate (TU) + norethisterone enanthate (NET-EN
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase II
Export to Excel